Fennec Pharmaceuticals

FENCNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$403.814 M

$11.58 +6.78%

Close of 7 Aug 2026

Revenue

$44.6M

#2779 by revenue

Earnings

-$9.74B

Loss-making

Shares outstanding

34,475,178

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#77Sutro BiopharmaSTRO$420.6M
#78C4 TherapeuticsCCCC$412.4M
#79Fennec PharmaceuticalsFENC$403.8M
#80Compass TherapeuticsCMPX$387.2M
#81Lexeo TherapeuticsLXEO$377.7M

Where these numbers come from

Share counts and financials for Fennec Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.